Condensed Consolidated Statements Stockholders' Equity - USD ($)	Common Stock	Additional Paid-in capital	Other comprehensive loss	Accumulated deficit	Total
Equity, beginning balance at Dec. 31, 2020	$ 21,187	$ 231,418,356	$ (10,037,261)	$ (144,007,075)	$ 77,395,207
Equity, beginning balance (in shares) at Dec. 31, 2020	21,186,827
Increase (Decrease) in Stockholders' Equity
Stockbased compensation		1,822,562			1,822,562
Foreign currency translation			(402,850)		(402,850)
Net loss				(9,668,755)	(9,668,755)
Equity, ending balance at Mar. 31, 2021	$ 21,187	233,240,918	(10,440,111)	(153,675,830)	69,146,164
Equity, ending balance (in shares) at Mar. 31, 2021	21,186,827
Equity, beginning balance at Dec. 31, 2021	$ 21,859	240,978,439	(10,358,956)	(181,134,378)	49,506,964
Equity, beginning balance (in shares) at Dec. 31, 2021	21,859,413
Increase (Decrease) in Stockholders' Equity
Vesting of restricted stock units	$ 115	(115)
Vesting of restricted stock units (in shares)	114,889
Stockbased compensation		2,084,060			2,084,060
Foreign currency translation			(65,505)		(65,505)
Net loss				(7,936,693)	(7,936,693)
Equity, ending balance at Mar. 31, 2022	$ 21,974	$ 243,062,384	$ (10,424,461)	$ (189,071,071)	$ 43,588,826
Equity, ending balance (in shares) at Mar. 31, 2022	21,974,302